Neoadjuvant ipilimumab and nivolumab immunotherapy could become new standard of care for resectable stage III melanoma

Pancreatic neuroendocrine tumours: Capecitabine plus temozolomide gives longer PFS than temozolomide alone

ctDNA sequencing detects outcomes for pretreated advanced gastrointestinal stromal tumour

FOLFOXIRI plus panitumumab vs mFOLFOX6/PAN for unresectable RAS and BRAF wild-type mCC

Comment: Panitumumab plus mFOLFOX6 improves OS for RAS wild-type left sided mCRC

Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Comment: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Trastuzumab deruxtecan doubles PFS in metastatic breast cancer with low HER2 expression

Comment:Trifluridine/tipiracil, bevacizumab + trifluridine/tipiracil provides benefits for metastatic colorectal cancer patients

Comment: (RVd) ± , stem cell transplantation and R maintenance shows significance for newly diagnosed myeloma patients

Comment: Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide for refractory Ewing sarcoma patients